首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
DRIVE CHAIN
摘要
申请公布号
GB2093423(A)
申请公布日期
1982.09.02
申请号
GB19820004140
申请日期
1982.02.12
申请人
WEC
发明人
分类号
B66B23/02;B65G23/16;F16G13/06;(IPC1-7):B65G23/14
主分类号
B66B23/02
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Mesenchymal Stem Cells Producing Inhibitory RNA for Disease Modification
ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS
T CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND USES THEREOF
MERCAPTO-MODIFIED BIOCOMPATIBLE MACROMOLECULE DERIVATIVES WITH LOW DEGREE OF MERCAPTO-MODIFICATION AND THE CROSS-LINKED MATERIALS AND USES THEREOF
COMPOSITION & METHODS OF SCREENING
Controlled Release Doxycycline
COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION
ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
MULTIDRUG INFUSION FOR PAIN CONTROL
PHARMACEUTICAL COMPOSITION OF BUPROPION AND NALTREXONE
METHODS FOR TREATING NEWLY DIAGNOSED MULTIPLE MYELOMA WITH 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE IN COMBINATION WITH SECOND ACTIVE AGENTS
SECURININE AND NORSECURININE ANALOGUE COMPOUNDS FOR THE TREATMENT OF MYELOID DISORDERS
NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
SUPER-OXIDE DISMUTASE MIMETICS
SIRT 1 ACTIVATOR INCLUDING SYRINGARESINOL
Controlled Release Dosage Form
OSMOTIC DRUG DELIVERY SYSTEM
SUSTAINED RELEASE FORMULATION OF NALBUPHINE
Medical Connecting Device
Seat Assembly For A Passenger Conveyance Device
